红日药业(300026)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300026 红日药业

已收盘 12-18 15:00:00

{"stockData":{"symbol":"300026","market":"SZ","secType":"STK","nameCN":"红日药业","latestPrice":3.58,"timestamp":1766041431000,"preClose":3.58,"halted":0,"volume":24037023,"delay":0,"changeRate":0,"floatShares":2739000000,"shares":3004000000,"eps":-0.0221,"marketStatus":"已收盘","change":0,"latestTime":"12-18 15:00:00","open":3.56,"high":3.6,"low":3.55,"amount":86111100,"amplitude":0.014,"askPrice":3.58,"askSize":379,"bidPrice":3.57,"bidSize":7812,"shortable":0,"etf":0,"ttmEps":-0.0221,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766107800000},"marketStatusCode":5,"adr":0,"adjPreClose":3.58,"symbolType":"stock","openAndCloseTimeList":[[1766021400000,1766028600000],[1766034000000,1766041200000]],"highLimit":3.94,"lowLimit":3.22,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":3004154837,"isCdr":false,"pbRate":1.25,"roa":"--","roe":"0.93%","epsLYR":0.01,"committee":-0.29889,"marketValue":10755000000,"turnoverRate":0.0088,"status":2,"floatMarketCap":9804000000},"requestUrl":"/m/hq/s/300026/wiki","defaultTab":"wiki","newsList":[{"id":"2591639410","title":"天津红日药业修订董事会战略委员会实施细则","url":"https://stock-news.laohu8.com/highlight/detail?id=2591639410","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591639410?lang=zh_cn&edition=full","pubTime":"2025-12-13 15:26","pubTimestamp":1765610768,"startTime":"0","endTime":"0","summary":"中访网数据 天津红日药业股份有限公司于2025年12月12日召开董事会，审议通过了修订后的《董事会战略委员会实施细则》。此次修订主要依据最新的《上市公司独立董事管理办法》等法规要求，对委员会的人员组成、职责权限及议事规则进行了更新与完善。细则明确了委员会的议事程序，要求会议需有三分之二以上委员出席方可举行，决议须经全体委员过半数通过。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251213/31864365.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0188","BK0239","300026","BK0077"],"gpt_icon":0},{"id":"2586276742","title":"红日药业：公司药品主要分为中药配方颗粒和成品药","url":"https://stock-news.laohu8.com/highlight/detail?id=2586276742","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586276742?lang=zh_cn&edition=full","pubTime":"2025-11-28 08:42","pubTimestamp":1764290531,"startTime":"0","endTime":"0","summary":"证券之星消息，红日药业(300026)11月27日在投资者关系平台上答复投资者关心的问题。投资者提问：你好，董秘，请问贵公司有面向治疗流感的药品吗，治疗流感类的药品在贵司营业额所占比例份额大吗红日药业回复：您好，公司药品主要分为中药配方颗粒和成品药。中药配方颗粒是需要医生开具处方的颗粒制剂，成品药包括血必净注射液、安若泰、博璞宁、博璞艾等处方药。感谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112800003882.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","BK0077","300026"],"gpt_icon":0},{"id":"2584038621","title":"红日药业（300026）披露拟续聘会计师事务所议案获股东大会通过，11月17日股价下跌1.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584038621","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584038621?lang=zh_cn&edition=full","pubTime":"2025-11-17 22:26","pubTimestamp":1763389589,"startTime":"0","endTime":"0","summary":"截至2025年11月17日收盘，红日药业报收于3.91元，较前一交易日下跌1.01%，最新总市值为117.46亿元。公司近日发布公告称，天津红日药业股份有限公司于2025年11月17日召开2025年第三次临时股东大会，采用现场与网络投票相结合方式，审议通过《关于拟续聘会计师事务所的议案》。出席会议股东共576人，代表股份723,146,879股，占公司总股本的24.0716%。议案同意票占出席会议有效表决权的98.8723%，中小投资者同意票占比84.6085%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111700037120.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","300026","BK0077"],"gpt_icon":0},{"id":"2583580908","title":"红日药业：湖州展望产能规划基于市场需求","url":"https://stock-news.laohu8.com/highlight/detail?id=2583580908","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583580908?lang=zh_cn&edition=full","pubTime":"2025-11-13 08:54","pubTimestamp":1762995255,"startTime":"0","endTime":"0","summary":"证券之星消息，红日药业(300026)11月12日在投资者关系平台上答复投资者关心的问题。投资者提问：贵公司湖州展望产能扩张后，能否实现满产满销？红日药业回复：您好，湖州展望的产能规划，是基于对市场需求、区域产业政策及自身技术优势的综合判断。公司积极参与产业链对接、紧跟政策导向、开拓市场来确保销路畅通。在生产端，大力推进技术改造与智能化升级，以确保产品具备强劲的市场竞争力。同时，我们时刻关注市场风险，建立了灵活、高效的生产管理与风险应对机制。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111300008144.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","300026","BK0077","BK0239"],"gpt_icon":0},{"id":"2583801580","title":"红日药业：哈三联是公司的委托生产企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2583801580","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583801580?lang=zh_cn&edition=full","pubTime":"2025-11-13 08:45","pubTimestamp":1762994718,"startTime":"0","endTime":"0","summary":"证券之星消息，红日药业(300026)11月12日在投资者关系平台上答复投资者关心的问题。投资者提问：贵公司跟哈尔滨三联药业属于什么关系？，两家公司有众多合作申报品种红日药业回复：您好，哈三联是公司的委托生产企业。谢谢关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111300007916.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","002900","BK0077","300026"],"gpt_icon":0},{"id":"2583808595","title":"红日药业：经典名方研发同质化加剧","url":"https://stock-news.laohu8.com/highlight/detail?id=2583808595","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583808595?lang=zh_cn&edition=full","pubTime":"2025-11-13 08:39","pubTimestamp":1762994351,"startTime":"0","endTime":"0","summary":"证券之星消息，红日药业(300026)11月12日在投资者关系平台上答复投资者关心的问题。投资者提问：在中药经典名方方面根据贵公司之前披露的信息，既有自己立项研发的诸多品种，又有对外合作项目，但迄今为止无任何项目申报注册，请问难点在哪里？贵公司如何看待如此的研发效率低于行业同行？红日药业回复：您好，目前经典名方研发同质化研发加剧，公司会根据市场和研发竞争情况调整申报策略。 感谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111300007888.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","300026","BK0188","BK0239"],"gpt_icon":0},{"id":"2583130203","title":"股市必读：红日药业（300026）11月12日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2583130203","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583130203?lang=zh_cn&edition=full","pubTime":"2025-11-13 03:44","pubTimestamp":1762976653,"startTime":"0","endTime":"0","summary":"截至2025年11月12日收盘，红日药业报收于3.86元，下跌0.26%，换手率1.88%，成交量51.5万手，成交额1.99亿元。董秘最新回复投资者： 利用目前资本市场的大好环境，通过投资并购的方式快速夯实公司主业发展是否是贵公司的优先事项？当日关注点来自交易信息汇总：11月12日主力资金净流出758.93万元，散户资金净流入908.04万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111300004632.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0188","300026","BK0239"],"gpt_icon":0},{"id":"2581326833","title":"红日药业新注册《销售信息门户平台V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2581326833","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581326833?lang=zh_cn&edition=full","pubTime":"2025-11-08 02:00","pubTimestamp":1762538449,"startTime":"0","endTime":"0","summary":"证券之星消息，近日红日药业（300026）新注册了《销售信息门户平台V1.0》项目的软件著作权。今年以来红日药业新注册软件著作权4个，较去年同期减少了20%。结合公司2025年中报财务数据，今年上半年公司在研发方面投入了9291.12万元，同比减0.83%。通过天眼查大数据分析，天津红日药业股份有限公司共对外投资了23家企业，参与招投标项目915次；财产线索方面有商标信息283条，专利信息166条，著作权信息39条；此外企业还拥有行政许可184个。数据来源：天眼查APP以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110800000884.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","300026","BK0239","BK0188"],"gpt_icon":0},{"id":"2581833016","title":"红日药业新注册《票据中心系统V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2581833016","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581833016?lang=zh_cn&edition=full","pubTime":"2025-11-07 01:50","pubTimestamp":1762451427,"startTime":"0","endTime":"0","summary":"证券之星消息，近日红日药业（300026）新注册了《票据中心系统V1.0》项目的软件著作权。今年以来红日药业新注册软件著作权3个，较去年同期减少了40%。结合公司2025年中报财务数据，今年上半年公司在研发方面投入了9291.12万元，同比减0.83%。通过天眼查大数据分析，天津红日药业股份有限公司共对外投资了23家企业，参与招投标项目915次；财产线索方面有商标信息283条，专利信息166条，著作权信息39条；此外企业还拥有行政许可184个。数据来源：天眼查APP以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110700001132.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","BK0077","300026"],"gpt_icon":0},{"id":"2581643940","title":"红日药业最新公告：股东姚小青及高管拟合计减持不超1.576%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2581643940","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581643940?lang=zh_cn&edition=full","pubTime":"2025-11-06 19:49","pubTimestamp":1762429796,"startTime":"0","endTime":"0","summary":"红日药业(300026.SZ)公告称，持股5%以上股东姚小青计划减持不超过4,693.63万股（占总股本的1.5624%），高级管理人员陈瑞强计划减持不超过16.90万股（占总股本的0.0056%），张坤计划减持不超过23.20万股（占总股本的0.0077%）。减持原因为个人资金需求，减持方式为集中竞价或大宗交易，减持期间为公告披露之日起十五个交易日后的三个月内。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110600034221.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","300026","BK0239","BK0188"],"gpt_icon":0},{"id":"2579978642","title":"红日药业(300026)9月30日股东户数9.63万户，较上期减少4.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579978642","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579978642?lang=zh_cn&edition=full","pubTime":"2025-10-29 17:32","pubTimestamp":1761730361,"startTime":"0","endTime":"0","summary":"证券之星消息，近日红日药业披露，截至2025年9月30日公司股东户数为9.63万户，较6月30日减少4519.0户，减幅为4.48%。在中药行业个股中，红日药业股东户数高于行业平均水平，截至9月30日，中药行业平均股东户数为5.34万户。从股价来看，2025年6月30日至2025年9月30日，红日药业区间跌幅为0.0%，在此期间股东户数减少4519.0户，减幅为4.48%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900036314.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0188","300026","BK0239"],"gpt_icon":0},{"id":"2578995516","title":"图解红日药业三季报：第三季度单季净利润同比下降89.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578995516","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578995516?lang=zh_cn&edition=full","pubTime":"2025-10-28 19:36","pubTimestamp":1761651371,"startTime":"0","endTime":"0","summary":"证券之星消息，红日药业2025年三季报显示，公司主营收入41.49亿元，同比下降6.59%；归母净利润8076.29万元，同比下降52.03%；扣非净利润8870.48万元，同比下降43.81%；其中2025年第三季度，公司单季度主营收入13.54亿元，同比下降6.32%；单季度归母净利润213.29万元，同比下降89.4%；单季度扣非净利润1952.51万元，同比下降6.07%；负债率18.24%，投资收益-287.46万元，财务费用1005.5万元，毛利率52.19%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102800036124.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300026"],"gpt_icon":0},{"id":"2569041782","title":"红日药业：聚力精益管理数字化赋能降本增效","url":"https://stock-news.laohu8.com/highlight/detail?id=2569041782","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569041782?lang=zh_cn&edition=full","pubTime":"2025-09-22 16:00","pubTimestamp":1758528043,"startTime":"0","endTime":"0","summary":"证券之星消息，红日药业(300026)09月22日在投资者关系平台上答复投资者关心的问题。投资者提问：贵公司口口声声降本增效，请问具体举措是什么？是否尽快裁掉冗员？红日药业回复：您好，“降本增效”是公司经营主线之一，在各业务板块中贯彻执行。公司通过聚力精益管理、数字化赋能及研产销协同等多维举措，系统性降本增效，驱动高质量发展。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092200018484.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300026","BK0077","BK0188","BK0239"],"gpt_icon":0},{"id":"2569046632","title":"红日药业：构建自有线下医馆闭环生态体系","url":"https://stock-news.laohu8.com/highlight/detail?id=2569046632","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569046632?lang=zh_cn&edition=full","pubTime":"2025-09-22 15:54","pubTimestamp":1758527652,"startTime":"0","endTime":"0","summary":"证券之星消息，红日药业09月22日在投资者关系平台上答复投资者关心的问题。请问贵公司的上医明家实体线下医馆是不是迎来了前所未有的发展契机？","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092200017585.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","300026","BK0239","BK0188"],"gpt_icon":0},{"id":"2568232347","title":"红日药业某全资子公司被福建医保局失信评级定”一般”","url":"https://stock-news.laohu8.com/highlight/detail?id=2568232347","media":"中金财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568232347?lang=zh_cn&edition=full","pubTime":"2025-09-19 14:04","pubTimestamp":1758261853,"startTime":"0","endTime":"0","summary":"中国经济网北京9月19日讯 福建省医疗保障局网站近期发布了福建省药械联合采购中心关于公布福建省第九批信用评级企业名单的通知。　　根据《福建省医疗保障局关于建立医药价格和招采信用评价制度的通知》有关规定，现对下列2家企业予以信用评级，北京康仁堂药业有限公司与贵州三力制药股份有限公司信用评级为一般。　　红日药业年报显示，北京康仁堂药业有限公司为公司全资子公司。","market":"sh","thumbnail":" http://caiji.3g.cnfol.com/colect/202509/19/20250919743027.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202509/19/20250919743027.png"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20250919/31657232.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["300026"],"gpt_icon":0},{"id":"2567869024","title":"红日药业（300026）披露2025年第二次临时股东大会法律意见书，9月16日股价上涨1.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2567869024","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567869024?lang=zh_cn&edition=full","pubTime":"2025-09-16 22:27","pubTimestamp":1758032840,"startTime":"0","endTime":"0","summary":"截至2025年9月16日收盘，红日药业报收于3.92元，较前一交易日上涨1.29%，最新总市值为117.76亿元。该股当日开盘3.88元，最高3.93元，最低3.86元，成交额达1.9亿元，换手率为1.78%。公告显示，北京市康达律师事务所对天津红日药业股份有限公司2025年第二次临时股东大会出具法律意见书。本次会议由公司董事会召集，于2025年9月16日以现场和网络投票方式召开。其中中小投资者股东同意股份数占该类股东所持表决权的73.2537%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091600038217.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0239","300026","BK0188"],"gpt_icon":0},{"id":"2566321627","title":"研报掘金丨国海证券：首予红日药业“增持”评级，长期看好配方颗粒国标实施后成长空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2566321627","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566321627?lang=zh_cn&edition=full","pubTime":"2025-09-10 14:08","pubTimestamp":1757484508,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0077","BK0239","BK0188","300026","BK0276","BK0174","BK0183","000750","BK0028"],"gpt_icon":0},{"id":"2566612060","title":"股市必读：红日药业（300026）9月9日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2566612060","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566612060?lang=zh_cn&edition=full","pubTime":"2025-09-10 02:12","pubTimestamp":1757441537,"startTime":"0","endTime":"0","summary":"截至2025年9月9日收盘，红日药业报收于3.84元，下跌1.79%，换手率1.64%，成交量44.92万手，成交额1.74亿元。当日关注点来自交易信息汇总：9月9日主力资金净流出2114.62万元，散户资金净流入1250.01万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091000001498.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0188","300026","BK0239"],"gpt_icon":0},{"id":"2566667191","title":"红日药业：创新药研发周期漫长存在不确定性","url":"https://stock-news.laohu8.com/highlight/detail?id=2566667191","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566667191?lang=zh_cn&edition=full","pubTime":"2025-09-09 16:30","pubTimestamp":1757406646,"startTime":"0","endTime":"0","summary":"证券之星消息，红日药业09月09日在投资者关系平台上答复投资者关心的问题。是人不行还是钱不行 还是都不行红日药业回复：您好，公司深刻理解投资者对研发成果的期待。创新药研发周期漫长，存在不确定性。当前研发投入已转化为阶段性成果，但距离上市仍需时间。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090900026295.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159992","BK0077","300026","BK1574","BK0188","BK0239","BK1161","06978"],"gpt_icon":0},{"id":"2564393323","title":"红日药业：公司会严格按照相关规定及时履行信息披露义务","url":"https://stock-news.laohu8.com/highlight/detail?id=2564393323","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564393323?lang=zh_cn&edition=full","pubTime":"2025-09-03 19:08","pubTimestamp":1756897680,"startTime":"0","endTime":"0","summary":"登录新浪财经APP 搜索【信披】查看更多考评等级\n证券日报网讯红日药业9月3日在互动平台回答投资者提问时表示，公司会严格按照相关规定及时履行信息披露义务。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-09-03/doc-infpfnya7680755.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-09-03/doc-infpfnya7680755.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0188","300026","BK0077","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1766077557822,"stockEarnings":[{"period":"1week","weight":-0.0083},{"period":"1month","weight":-0.0701},{"period":"3month","weight":-0.0453},{"period":"6month","weight":-0.0165},{"period":"1year","weight":-0.1219},{"period":"ytd","weight":-0.0476}],"compareEarnings":[{"period":"1week","weight":0.0008},{"period":"1month","weight":-0.0161},{"period":"3month","weight":0.0147},{"period":"6month","weight":0.1537},{"period":"1year","weight":0.1461},{"period":"ytd","weight":0.1565}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"天津红日药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"96308人(较上一季度减少4.48%)","perCapita":"28435股","listingDate":"2009-10-30","address":"天津市武清区新技术产业园区武清开发区泉发路西","registeredCapital":"300415万元","survey":"　　天津红日药业股份有限公司的主营业务是药品及医疗器械的生产经营和研究开发。公司的主要产品是中药配方颗粒、成品药、医疗器械、原辅料、医疗健康服务和药械智慧供应链。公司全资子公司北京康仁堂荣获“北京市先进级智能工厂”“全国文明单位”称号；全资孙公司山东康仁堂荣获“济南市第二十一批农业产业化重点龙头企业”称号、及“2024年跨越发展奖”“2024年科技人才奖”“2024年项目贡献奖”三项商河县政府奖项；全资孙公司重庆康仁堂荣获“重庆市优秀民营企业”称号、成功通过重庆市专精特新中小企业复审，再次荣获“重庆市专精特新中小企业”称号。","listedPrice":60},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"红日药业(300026)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供红日药业(300026)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"红日药业,300026,红日药业股票,红日药业股票老虎,红日药业股票老虎国际,红日药业行情,红日药业股票行情,红日药业股价,红日药业股市,红日药业股票价格,红日药业股票交易,红日药业股票购买,红日药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"红日药业(300026)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供红日药业(300026)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}